Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HHK001 vs Enantone in Endometriosis
NCT07755956Phase 1Recruiting
- Sponsor
- Huahaikang Pharmaceutical
- Start
- Oct 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 1 trial of HHK001 in endometriosis (2 arms), sponsored by Huahaikang Pharmaceutical. Primary endpoints: Concentrations of leuprorelin acetate and Concentrations of estradiol. Started Oct 2026; status: recruiting.
02
Drugs
HHK001
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT07755956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07755956.